Osaka, Japan – Technological advances have enabled scientists to obtain massive amounts of data on different information-carrying molecules in cells and tissues, such as DNA, proteins and various forms of RNA. However, to date, it has been difficult to perform integrated analyses of such information to further our knowledge on the molecules and processes involved in the development of particular diseases.
Researchers from an Osaka University-led collaboration have made a major contribution to our understanding of the complex relationships among the components of cells and tissues. They have established a new analytical approach called MIGWAS that integrates information from two different sources. One of these is associations between genetic variants and diseases and other traits, while the other is data about networks formed between small regulatory molecules called miRNAs and the genes that they target. The team showed that this in silico screening approach provides improved power to reveal novel cellular components associated with diseases and other traits, tissue-specifically.
The use of miRNA data in this way was prompted by accumulating findings on the importance of miRNAs in various physiological functions and diseases. miRNAs are small products of DNA that do not themselves encode proteins, but instead bind to mRNAs to regulate gene expression. In this latest study, the researchers employed previously obtained data on the expression of around 1,800 miRNAs in different cells. They searched for overlaps between these miRNAs and the genes they target on the one hand, and genes identified elsewhere as being linked to diseases and other traits by studies focusing directly on the genetic code on the other.
“It has been difficult to obtain convincing data about the effects of miRNAs as their short length means that they are encoded by only a very small part of the genome,” lead author Saori Sakaue says. “Our MIGWAS approach linking findings from genome-wide association studies and miRNA-target networks helps to overcome this. It successfully obtained significant results for miRNA/target gene enrichment for traits such as height and type 2 diabetes across different ethnic groups.”
The team attempted to validate this approach by focusing on the disease rheumatoid arthritis (RA), using data on single-nucleotide polymorphisms from nearly 20,000 RA cases and over 60,000 corresponding controls. This revealed four miRNAs linked to RA that were also identified by the MIGWAS pipeline, one of which was significantly highly expressed in RA patients.
“The analytical power of our approach shows its potential for finding new networks of miRNAs and their target genes linked to traits and diseases, in a tissue-specific way,” corresponding author Yukinori Okada says. “This should make it easier to find new targets that we can focus on for developing therapeutic strategies for a wide range of diseases.”
The article “Integration of genetics and miRNA-target gene network identified disease biology implicated in tissue specificity” is published in Nucleic Acids Research at doi: https:/
About Osaka University
Osaka University was founded in 1931 as one of the seven imperial universities of Japan and now has expanded to one of Japan’s leading comprehensive universities. The University has now embarked on open research revolution from a position as Japan’s most innovative university and among the most innovative institutions in the world according to Reuters 2015 Top 100 Innovative Universities and the Nature Index Innovation 2017. The university’s ability to innovate from the stage of fundamental research through the creation of useful technology with economic impact stems from its broad disciplinary spectrum.
Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.